Association between Lp (a) and atherosclerosis in menopausal women without metabolic syndrome

Biomarkers in Medicine

Volumn 10, Issue 4, 2016, Pages 397-402

  Gentile, Marco ^a   Iannuzzo, Gabriella ^a   Mattiello, Amalia ^a   Marotta, Gennaro ^a   Iannuzzi, Arcangelo ^b   Panico, Salvatore ^a   Rubba, Paolo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CARDARELLI HOSPITAL   (Italy)

Author keywords

atherosclerosis; cardiovascular risk; Lp (a); metabolic syndrome; ultrasound; women

Indexed keywords

LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; GLUCOSE BLOOD LEVEL; LIPOPROTEIN A;

ADULT; AGE DISTRIBUTION; AGED; ARTERIAL WALL THICKNESS; ARTICLE; B SCAN; CAROTID ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PROTEIN DETERMINATION; PROTEIN FUNCTION; WAIST CIRCUMFERENCE; ANALYSIS; ATHEROSCLEROSIS; BLOOD; BLOOD PRESSURE; COMPLICATION; GLUCOSE BLOOD LEVEL; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR;

ADULT; AGED; ATHEROSCLEROSIS; BLOOD GLUCOSE; BLOOD PRESSURE; CAROTID INTIMA-MEDIA THICKNESS; CHOLESTEROL, LDL; FEMALE; HUMANS; LIPOPROTEIN(A); MENOPAUSE; METABOLIC SYNDROME X; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 84962194634     PISSN: 17520363     EISSN: 17520371     Source Type: Journal    
DOI: 10.2217/bmm.16.4     Document Type: Article

References (21)

1. Scanu AM, Lawn RM, Berg K. Lipoprotein(a) and atherosclerosis. Ann. Intern. Med. 115, 209-218 (1991).
2. Lamon-Fava S, Diffenderfer MR, Marcovina SM. Lipoprotein (a) metabolism. Curr. Opin. Lipidol. 25, 189-193 (2014).
3. Koschinsky M, Boffa M. Lipoprotein(a) as a therapeutic target in cardiovascular disease. Expert Opin. Ther. Targets 18, 747-757 (2014).
4. Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, Nordestgaard BG. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA 301, 2331-2339 (2009).
5. Khawaja FJ, Kullo IJ. Novel markers of peripheral arterial disease. Vasc. Med. 14, 381-392 (2009).
6. The Emerging Risk Factors Collaboration. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 302, 412-423 (2009).
7. O'Leary DH, Polak JF, Kronmal RA et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 340, 14-22 (1999).
8. Rubba P, Panico S, Bond MG et al. Site-specific atherosclerotic plaques in the carotid arteries of middle-aged women from southern Italy: associations with traditional risk factors and oxidation markers. Stroke 32, 1953-1959 (2001).
9. Panico S, Dello Iacovo R, Celentano E et al. Progetto ATENA, a study on the etiology of major chronic diseases in women: design, rationale and objectives. Eur. J. Epidemiol. 8, 601-608 (1992).
10. Rubba F, Mattiello A, Chiodini P et al. Menstrual cycle length, serum lipids and lipoproteins in a cohort of Italian Mediterranean women: findings from Progetto ATENA. Nutr. Metab. Cardiovasc. Dis. 18, 659-663 (2008).
11. Gentile M, Panico S, Mattiello A et al. Association between small dense LDL and early atherosclerosis in a sample of menopausal women. Clin. Chim. Acta 426, 1-5 (2013).
12. De Michele M, Panico S, Iannuzzi A et al. Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 33, 2923-2928 (2002).
13. Tang R, Hennig M, Bond MG et al. Baseline reproducibility of B-mode ultrasonic measurement of carotid artery intima-media thickness: The European Lacidipine Study on Atherosclerosis (ELSA). J. Hypertens. 18, 197-201 (2000).
14. Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institute scientific statement: executive summary. Circulation 112, 285-290 (2005).
15. Volpato S, Vigna GB, Mc Dermott MM et al. Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women the In CHIANTI study. Am. J. Cardiol. 105, 1825-1830 (2010).
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412-419 (1985).
17. Sung KC, Wild SH, Byrne CD. Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort. Nutr. Metab. Cardiovasc. Dis. 23, 1239-1246 (2013).
18. Marzano L, Colussi G, Del Torre M et al. Relationships of plasma lipoprotein(a) levels with insulin resistance in hypertensive patients. Metabolism 63, 1439-1446 (2014).
19. Neele DM, de Wit EC, Princen HM. Insulin suppresses apolipoprotein(a) synthesis by primary cultures of cynomolgus monkey hepatocytes. Diabetologia 42, 41-44 (1999).
20. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 96, 1432-1437 (1997).
21. Koschinsky M, Boffa M. Lipoprotein(a) as a therapeutic target in cardiovascular disease. Expert Opin. Ther. Targets 18, 747-757 (2014).